Related Experiment Video
Updated: Oct 16, 2025

05:47
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
742
A sui generis QA approach using RoBERTa for adverse drug event identification
Harshit Jain1, Nishant Raj2, Suyash Mishra3
1ZS Associates, Bengaluru, India.
BMC Bioinformatics
|October 22, 2021
Summary
This study introduces a question answering framework using RoBERTa for improved adverse drug event extraction from biomedical text. Our model significantly outperforms previous methods, enhancing drug safety monitoring.
Area of Science:
- Biomedical Informatics
- Natural Language Processing
- Pharmacovigilance
Background:
- Monitoring drug safety through adverse drug event (ADE) extraction from biomedical literature is crucial.
- Existing entity-relation extraction methods, often using Bi-LSTM, lack optimal feature representation.
Purpose of the Study:
- To develop an improved framework for extracting ADEs from biomedical text.
- To overcome limitations of existing methods by leveraging advanced NLP techniques.
Main Methods:
- A question answering (QA) framework utilizing RoBERTa (Robustly Optimized BERT Pretraining Approach).
- Domain adaptation techniques applied to RoBERTa.
- An end-to-end pipeline integrating QA and transformer architecture.
Main Results:
- The proposed QA framework with RoBERTa achieved a 9.53% higher F1-Score compared to prior work.
- Demonstrated superior performance in entity-relation extraction for ADEs.
Conclusions:
- An end-to-end pipeline combining transformer architecture and QA significantly enhances biomedical entity-relation extraction.
- This approach is valuable for identifying potential adverse drug reactions in various therapeutic contexts.
Related Concept Videos
Pharmacovigilance
1.1K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.1K
Structure-Activity Relationships and Drug Design
1.2K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.2K
Drug Regulation
2.1K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.1K
Drug Discovery: Overview
9.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.5K
Dosage Regimen: Individualization
16
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
16
Drug Nomenclature
2.5K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
2.5K

